Biographical Sketch
Adam W. Grasso, MD, PhD, is a staff cardiologist in the Section of Clinical Cardiology, the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, at the Sydell and Arnold Miller Family Heart & Vascular Institute. He began his appointment as a Fellow in the Department of Cardiovascular Medicine in 2004. Prior to this, he completed both his internship and residency in internal medicine at the University of Washington School of Medicine, in Seattle. Additionally, Dr. Grasso earned a PhD in 1999 from the Department of Molecular Biology and Microbiology at Case Western Reserve University School of Medicine, in Cleveland, Ohio. His specialty interests include cardiac consultation, clinical research in cardiology, atherosclerosis, lipid-lowering therapy and invasive cardiology.
He is currently board-certified in internal medicine and cardiovascular medicine.
Dr. Grasso is a graduate of the Case Western Reserve University School of Medicine. He received his undergraduate degree from the University of Pennsylvania, in Philadelphia, majoring in chemistry and graduating Cum Laude.
Dr. Grasso was named the Fredric J. Pashkow Stress Lab Fellow of the Year in the Department of Cardiovascular Medicine at Cleveland Clinic in 2005. He received the Outstanding Resident Award from the American Federation for Medical Research-Western Section in 2003, and an American Institute of Chemists Award in 1992.
His research has been published in numerous peer-reviewed medical journals and he has also contributed chapters to medical textbooks. In what time remains, he enjoys his young family, including a ten-year-old son and six-year-old daughter.
Specialty Interests
invasive cardiology, atherosclerosis, lipid-lowering therapy, clinical cardiology
Industry Relationships
Cleveland Clinic physicians and scientists report if they
have any collaborations with the pharmaceutical or medical
device industries as part of the Cleveland Clinic’s
procedures. The Cleveland Clinic publicly discloses
payments to its physicians and scientists for speaking and
consulting of $5,000 or more per year, and any equity,
royalties, and fiduciary relationships in companies with
which they collaborate. In publicly disclosing this
information, the Cleveland Clinic tries to provide
information as accurately as possible about its doctors’
connections with industry and those of their immediate
family members. As of 7/30/2008,
Dr. Grasso has reported no financial relationship with
industry that is applicable to this listing. Patients
should feel free to contact their doctor about
relationships with industry and how the relationships are
overseen by the Cleveland Clinic. To learn more about
the Cleveland Clinic’s policies on collaborations with
industry and innovation management, go to our
Integrity in Innovation page.
